CIDRAP newsletters options
Cases are accelerating in multiple hot spots, causing the global total to climb from 400,000 to 500,000 cases in only 2 days.
Chinese researchers say that they can't rule out mother-to-baby transmission in 3 infected newborns.
Hospitalization rates in Los Angeles and New York City are doubling every few days.
An international team of surgeons this week released a set of recommendations for preventing surgical-site infections (SSIs) that aim to improve patient outcomes, reduce unnecessary antibiotic exposure, and curb antibiotic resistance in low- and middle-income countries (LMICs).
About 70% of ICU patients got antibiotics, even though only 35% had positive culture tests.
The ECDC says the risk is very high if mitigation measures are inadequate.
The bill promises relief for many US households and small businesses.
Forge Therapeutics announced today that it will partner with Hoffman-La Roche to develop and commercialize a novel antibiotic for treating serious lung infections caused by antibiotic-resistant gram-negative bacteria.
The antibiotic, developed by Forge through its Fg-LpxC LUNG program, targets and inhibits LpxC, a zinc metalloenzyme found in gram-negative bacteria, using a proprietary chemistry platform.
Italian authors reported a 7.2% fatality rate—even higher in those 70 and older.
New York Governor Andrew Cuomo says the COVID-19 pandemic case count is doubling every 3 days in his state, as the WHO warns that the US could become the next global epicenter.
The WHO urges nations to maintain continuity of TB services as they respond to COVID-19.
More nations, including the UK and India, order countrywide lockdowns.
The World Health Organization's (WHO's) Special Programme for Research and Training in Tropical Diseases (TDR) announced late last week that 13 projects from 7 countries have been awarded funding for research on antimicrobial resistance (AMR).
Spain seems to be following Italy's trajectory, reporting 4,321 new cases and 33,090 total.
"We need you to understand you could be spreading it to someone else."
In 3 papers, experts lay out strategies for priority decisions on PPE, etc.
Guard troops will help efforts in New York, California, and Washington state.
The FDA authorizes an emergency use authorization for the first point-of-care rapid test.
The phenotypic tests measure nucleic acid in bacteria after exposure to antibiotics.
Governors in New, California, and Illinois announced new restrictions.
